Ciron Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.30 M
- Company Age 34 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.16 Cr
- Satisfied Charges ₹ 125.51 Cr
- Revenue Growth 4.53%
- Profit Growth 0.52%
- Ebitda 3.22%
- Net Worth 22.77%
- Total Assets 14.98%
About Ciron Drugs And Pharmaceuticals
Ciron Drugs And Pharmaceuticals Private Limited (CDAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 June 1990 and has a history of 34 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.30 M.
The company currently has active open charges totaling ₹21.16 Cr. The company has closed loans amounting to ₹125.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kirti Shah, Samir Shah, Keyur Shah, and Two other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24246MH1990PTC056735
-
Company No.
056735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jun 1990
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Ciron Drugs And Pharmaceuticals Private Limited offer?
Ciron Drugs And Pharmaceuticals Private Limited offers a wide range of products and services, including Product Engineering and Prototyping, Electronics Manufacturing Service.
Who are the key members and board of directors at Ciron Drugs And Pharmaceuticals?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Samir Shah
![]() |
Director | 10-Jul-2000 | Current |
Keyur Shah
![]() |
Director | 15-Feb-2016 | Current |
Kirti Shah
![]() |
Director | 18-Jun-2005 | Current |
Madan Hiwale
![]() |
Director | 12-May-2021 | Current |
Biswajit Paul
![]() |
Director | 12-May-2021 | Current |
Financial Performance of Ciron Drugs And Pharmaceuticals.
Ciron Drugs And Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.53% increase. The company also saw a slight improvement in profitability, with a 0.52% increase in profit. The company's net worth Soared by an impressive increase of 22.77%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ciron Drugs And Pharmaceuticals?
In 2022, Ciron Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹21.16 Cr
₹125.51 Cr
Charges Breakdown by Lending Institutions
- Others : 10.30 Cr
- Citi Bank N.A. : 10.00 Cr
- The Saraswat Co-Op. Bank Ltd : 0.83 Cr
- Citi Bank : 0.02 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Oct 2021 | Others | ₹10.00 Cr | Open |
17 Feb 2020 | Others | ₹3.04 M | Open |
25 Jul 2018 | Citi Bank N.A. | ₹10.00 Cr | Open |
07 Oct 1997 | Citi Bank | ₹0.23 M | Open |
02 Nov 1994 | The Saraswat Co-Op. Bank Ltd | ₹4.00 M | Open |
How Many Employees Work at Ciron Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Ciron Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Ciron Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ciron Drugs And Pharmaceuticals's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.